Tumor Markers 2021: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

March 2017 | 1200 pages | ID: T227935E2DDEN
Venture Planning Group

Abstracts

Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100.

Highlights

• Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years
• Examines trends in the U.S., Europe and Japan
• Reviews current and emerging tumor markers
• Analyzes applications of emerging diagnostic technologies
• Forecasts sales of major tumor markers by country and market segment
• Profiles leading market players and potential entrants
• Suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

France- Germany- Italy- Japan- Spain- UK- USA

Market Segmentation Analysis

• Sales and market shares of major suppliers, by individual tumor marker and country.
• Five-year test volume and sales forecasts for major tumor markers by country and market segment, including:
• Hospitals
• Commercial/Private Laboratories
• Physician Offices/Group Practices
• Cancer Clinics
• Ambulatory Care Centers
• Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country
• Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries.

Current and Emerging Products

• Review of over 200 current and emerging tumor markers, including:
• Biochemical Markers
• Oncogenes
• Growth Factors
• Hormones
• Colony Stimulating Factors
• Lymphokines
• Immunohistochemical Stains, and others.
• Analysis of major immunoassay analyzers used for tumor marker testing, including their operating characteristics, features and selling prices.

Technology Review

• Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and their potential applications for tumor marker testing.
• Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy.
• Extensive listings of over 500 companies, universities and research centers developing new tumor markers and detection technologies.

Competitive Assessments

Extensive strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. Worldwide Market Overview- Estimated universe of laboratories performing tumor marker testing by country.- Ten-year test volume and sales projections by country.Business Opportunities and Strategic Recommendations- Specific new product development opportunities with potentially significant market appeal during the next ten years.- Design criteria for new products.

Alternative market penetration strategies.

Potential market entry barriers and risks.MethodologyThis report is based on interviews with clinical pathologists, laboratory directors, executives from leading diagnostic companies and start-up firms developing innovative products, university scientists, as well as experts from industry associations, venture capital firms and the investment banking community in the U.S., five major European countries and Japan. The market projections are also based on questionnaire responses received from hospitals, commercial/private laboratories, physician offices/group practices, cancer clinics and ambulatory care centers in seven countries.In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product literature, patents, trade association surveys, government studies, marketing and technical meeting presentations, industry analyst reports, and VPGMarketResearchs proprietary data files was conducted. Contains 1,200 pages and 450 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET OVERVIEW

1. MARKET OVERVIEW
2. WORLDWIDE MARKET STRUCTURE
3. WORLDWIDE MARKET SIZE AND GROWTH

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Cancer Statistics and Etiology
  1. BREAST CANCER
  2. LUNG CANCER
  3. COLON AND RECTUM CANCER
  4. PROSTATE CANCER
  5. STOMACH CANCER
  6. LEUKEMIA
  7. LYMPHOMA
  8. ORAL CANCER
  9. SKIN CANCER
  10. UTERINE CANCER
  11. OVARIAN CANCER
  12. BLADDER CANCER
B. Major Current And Emerging Cancer Diagnostic Tests
  1. INTRODUCTION
  2. TUMOR MARKER CLASSIFICATION
  3. ACTH
  4. ALPHA-FETOPROTEIN (AFP)
  5. BETA-2 MICROGLOBULIN
  6. CA 15-3/27.29
  7. CA 19-9
  8. CA-125
  9. CALCITONIN
  10. CARCINOEMBRIONIC ANTIGEN (CEA)
  11. ESTROGEN AND PROGESTERONE RECEPTORS
  12. FERRITIN
  13. GASTRIN
  14. HUMAN CHORIONIC GONADOTROPIN (HCG)
  15. INSULIN
  16. NSE
  17. OCCULT BLOOD
  18. PAP SMEAR/HPV
  19. PROSTATIC ACID PHOSPHATASE (PAP)
  20. PROSTATE-SPECIFIC ANTIGEN (PSA)
  21. SQUAMOUS CELL CARCINOMA ANTIGEN (SCC)
  22. T AND B LYMPHOCYTES
  23. TDT
  24. THYROGLOBULIN
  25. TISSUE POLYPEPTIDE ANTIGEN (TPA)
  26. BIOCHEMICAL TUMOR MARKERS
  27. ONCOGENES
    Abl/abl-bcr
    AIB1
    BCL-2
    BRCA1
    CD44
    C-fos
    C-myb
    C-myc
    CYP-17
    Erb-B
    HPC1
    N-myc
    P40
    P51
    P53
    PIK3CA
    PTI-1
    Ras
    Reg
    Sis
    Src
  28. POLYPEPTIDE GROWTH FACTORS
    Basic Fibroblast Growth Factor
    Beta-TGF
    Cachectin (TNT)
    Calmodulin
    ECFR
    Nerve Growth Factor (NGF)
    Epidermal Growth Factor (EGF)
    Ornithine Decarboxylase
    Transferrin
    Transforming Growth Factor-Alpha
  29. ECTOPIC HORMONES
  30. COLONY STIMULATING FACTORS
  31. LYMPHOKINES
    Alpha-Interferon
    B Cell Growth Factors
    B Cell Growth Factor (BCGF)
    Gamma-Interferon
    Interleukin-1 (IL-1)
    Macrophage Activating Factor
  32. IMMUNOHISTOCHEMICAL STAINS
  33. EMERGING TUMOR MARKERS
    N-Acetylglucosamine
    Actin
    Alpha-Actin
    Antineuronal Antibodies
    7B2
    B72.3
    Bax
    BCD-F9
    BLCA-4
    Blood Group Antigens A,B,H
    CA
    CA 72-4/TAG-72
    CA
    CA-242
    CA-549
    CAM
    CAR-3
    Cathepsin-D
    Chromogranin A and B
    Cluster 1 Antigen
    Cluster-5/5A Antigen
    CTA
    CU18
    DR-70
    DU-PAN-2
    Endometrial Bleeding Associated Factor
    Endostatin
    Epithelial Membrane Antigen
    Feulgen Hydrolysis
    Fibronectin
    FSH
    (1->3)-L-fucosyltransferase
    Gastrin-Releasing Peptide (GRP)
    GDCFP-15
    Glucagon
    Glycoamines
    H23
    Her-2
    Human Carcinoma Antigen
    HPA
    HSP27
    Intermediate Filaments
    Cytokeratins/CK18/Cyfra 21-1
    Desmin
    Gliofibrillary Acid Protein
    Neurofilaments
    Vimentin
    KA
    Kinases
    KP16D3
    LAI
    Leukocyte Common Antigen
    Lewis Antigens
    Lysophosphatidic Acid (LPA)
    Ma 695/Ma
    MABDF3
    MAG
    ME1
    Minactivin
    MN/CA9
    MSA
    Mucin Cancer Antigen (MCA)
    Multiple Tumor Suppressor
    Myosin
    NEA-130
    NMP22
    OA-519
    Opioid Peptides
    P-glycoprotein
    Pancreatic Oncofetal Antigen (POA)
    Placental Lactogen
    PR92
    Proliferative Index, Ki-67
    Px
    RB Inactivation/Deletion
    Ret
    SCCL
    Selectin
    Sialic Acid
    Sialyl SSEA-1/SLX
    SN10
    Somatostatin
    TA-90
    TABA
    Tachykinin
    TAG
    TPS
    Troponin
    Tubulin
    VCAM
    VEGF
    Villen
C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
  1. MONOCLONAL AND POLYCLONAL ANTIBODIES
  2. IMMUNOASSAYS
  3. MOLECULAR DIAGNOSTICS
  4. CHROMOSOME ANALYSIS
    a. Chronic Myelogenous Leukemia (CML)
    b. Acute Myeloid Leukemia (AML)
    c. Acute Lymphoblastic Leukemia (ALL)
    d. Malignant Lymphomas Lymphoid Malignancies
    e. Chronic Lymphocytic Leukemia (CLL)
    f. Solid Cancers
    g. Chromosomal Translocation and Oncogenes
  5. ARTIFICIAL INTELLIGENCE
  6. FLOW CYTOMETRY
  7. TW DIMENSIONAL GEL ELECTROPHORESIS (2-DGE)
  8. BIOSENSORS
  9. COMPETING/COMPLEMENTING TECHNOLOGIES
E. Personal Testing

VIII. FRANCE CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

IX. GERMANY CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

X. ITALY CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

XI. JAPAN CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

XII. SPAIN CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

XIII. U.K. CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

XIV. U.S. CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

XV. COMPETITIVE PROFILES

Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo
Veridex
Wako Pure Chemicals
Wallac/PE
Zila

XVI. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS

List Of Tables

LIST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis Colony Stimulating Factors Potential
Applications in Cancer Diagnosis Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer Diagnostic Test Volume and Sales Forecast by Market Segment
France, Estimated Cancer Death Rates Per 100,000 Population
France, Laboratories Performing Tumor Marker Tests by Market Segment
France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume Forecast by Market Segment
France, All Market Segments Major Tumor Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
France, All Market Segments Major Tumor Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
France, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
France, Colon-Specific Antigen Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
France, Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
France, Progesterone Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
France, Thymidine Kinase Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
France, Total Tumor Marker Sales By Major Suppliers
France, AFP Testing Market Diagnostics Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
France, CA 125 Testing Market Diagnostics Sales by Major Supplier
France, CEA Testing Market Diagnostics Sales by Major Supplier
France, NSE Testing Market Diagnostics Sales by Major Supplier
France, PAP Testing Market Diagnostics Sales by Major Supplier
France, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
Germany, Estimated Cancer Death Rates Per 100,000 Population
Germany, Laboratories Performing Tumor Marker Tests by Market Segment
Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Germany, Total Tumor Marker Test Volume Forecast by Market Segment
Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
Germany, Total Tumor Marker Sales Forecast by Market Segment
Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Calcitonin Test Volumeand Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Chromogranin Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales By Major Supplier
Germany, AFP Testing Market Diagnostics Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
Germany, CEA Testing Market Diagnostics Sales by Major Supplier
Germany, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Estimated Cancer Death Rates Per 100,000 Population
Italy, Laboratories Performing Tumor Marker Tests by Market Segment
Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Italy, Total Tumor Marker Test Volume Forecast by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Italy, Total Tumor Marker Test Market Forecast by Market Segment
Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Beta-2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Chromogranin Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, Colon Specific Antigen Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, S-100 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Total Tumor Markers Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics Sales by Major Supplier
Italy, CEA Testing Market Diagnostics Sales by Major Supplier
Italy, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Japan, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
Japan, Estimated Cancer Death Rates Per 100,000 Population
Japan, Laboratories Performing Tumor Marker Tests by Market Segment
Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Japan, Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
Japan, Total Tumor Marker Testing Volume Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Test Volume Forecast
Japan, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Japan, Total Tumor Marker Sales Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Japan, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Colon-Specific Antigen Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, TPA, Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Total Tumor Marker Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
Japan, PAP Testing Market Diagnostics Sales by Major Supplier
Japan, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
Spain, Estimated Cancer Death Rates Per 100,000 Population
Spain, Laboratories Performing Tumor Marker Tests by Market Segment
Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Spain, Total Tumor Marker Test Volume Forecast by Market Segment
Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales Forecast by Market Segment
Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, S-100 Protein Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
Spain, CEA Testing Market Diagnostics Sales by Major Supplier
Spain, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
U.K., Estimated Cancer Death Rates Per 100,000 Population
U.K., Laboratories Performing Tumor Marker Tests by Market Segment
U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test Volumeand Diagnostics Sales by Market Segment
U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Total Tumor Marker Sales and Market Shares Forecast
U.K., CEA Testing Market Diagnostics Sales by Major Supplier
U.K., PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: U.S., Total Tumor Marker Test Volume and Sales Forecast By Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates Per 100,000 Population
U.S., Laboratories Performing Tumor Marker Tests by Market Segment
U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
U.S., Physician Office Laboratories Performing Tumor Marker Tests By Practice Size
U.S., Total Tumor Marker Test Volume Forecast by Market Segment
U.S., All Market Segments Major Tumor Marker Test Volume Forecast
U.S., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
U.S., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
U.S., Cancer Clinics Major Tumor Marker Test Volume Forecast by Test
U.S., Total Tumor Marker Sales Forecast by Market Segment
U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
U.S., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CEA Test Volume and Diagnostics Sales by Market Segment
U.S., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Colon-specific Antigen Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Interferons Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., Interleukins Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Total Tumor Marker Sales By Major Supplier
U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
U.S., AFP Testing Market Diagnostics Sales by Major Supplier
U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics Sales by Major Supplier
U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
U.S., HCG Testing Market Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics Sales by Major Supplier
U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics Sales by Major Supplier